We are live on ! Find out more
TVGN icon

Tevogen Bio Holdings

51 hedge funds and large institutions have $1.68M invested in Tevogen Bio Holdings in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

130% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 10

0% more ownership

Funds ownership: 0.05%0.05% (+0%)

6% less funds holding

Funds holding: 5451 (-3)

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

56% less capital invested

Capital invested by funds: $3.78M → $1.68M (-$2.1M)

Holders
51
Holders Change
-3
Holders Change %
-5.56%
% of All Funds
0.62%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
23
Reduced
10
Closed
10
Calls
Puts
Net Calls
Net Calls Change

TVGN Hedge Fund Activity: Q4 2025 in Review

51 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Tevogen Bio Holdings (TVGN) for Q4 2025, worth a combined $1.68M — down 56% from $3.78M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TVGN and 7 opened new positions — a net loss of 3 holders — while 10 trimmed existing stakes and 23 added.

The largest buyer was Goldman Sachs, adding an estimated $79.3K. The largest seller was BlackRock, cutting an estimated $186K.

  • 51 institutional investors held Tevogen Bio Holdings (TVGN) as of Q4 2025, down from 54 in Q3 2025.
  • Funds reported $1.68M of Tevogen Bio Holdings stock for Q4 2025, down 56% quarter-over-quarter.
  • 7 funds opened new Tevogen Bio Holdings positions in Q4 2025 and 10 closed out, a net change of -3 holders.
  • The largest Tevogen Bio Holdings buyer in Q4 2025 was Goldman Sachs, an estimated $79.3K added.
  • The largest Tevogen Bio Holdings seller in Q4 2025 was BlackRock, an estimated $186K sold.

Based on aggregated 13F filings for Q4 2025.